Clinical trial NCT01097694 - References

Asthma — Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)

Citation(s)

•   Al-Muhsen SZ, Shablovsky G, Olivenstein R, Mazer B, Hamid Q
  The expression of stem cell factor and c-kit receptor in human asthmatic airways. Clin Exp Allergy. 2004 Jun;34(6):911-6.
•   Bischoff SC, Dahinden CA
  c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med. 1992 Jan 1;175(1):237-44.
•   Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID
  Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002 May 30;346(22):1699-705.
•   Campbell E, Hogaboam C, Lincoln P, Lukacs NW
  Stem cell factor-induced airway hyperreactivity in allergic and normal mice. Am J Pathol. 1999 Apr;154(4):1259-65.
•   Carroll NG, Mutavdzic S, James AL
  Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax. 2002 Aug;57(8):677-82.
•   Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, Robinson D, Wenzel S, Busse W, Hansel TT, Barnes NC; International Mepolizumab Study Group
  . A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med. 2007 Dec 1;176(11):1062-71. Epub 2007 Sep 13.
•   Lukacs NW, Kunkel SL, Strieter RM, Evanoff HL, Kunkel RG, Key ML, Taub DD
  The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation. Blood. 1996 Mar 15;87(6):2262-8.
•   Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM
  Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009 Mar 5;360(10):985-93. doi: 10.1056/NEJMoa0805435.
•   Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions
  American Thoracic Society. Am J Respir Crit Care Med. 2000 Dec;162(6):2341-51. Review.
•   Reber L, Da Silva CA, Frossard N
  Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur J Pharmacol. 2006 Mar 8;533(1-3):327-40. Epub 2006 Feb 17. Review.
•   Yuan Q, Austen KF, Friend DS, Heidtman M, Boyce JA
  Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1). J Exp Med. 1997 Jul 21;186(2):313-23.

A 28 Week, Treatment Randomized, Double -Blind, Placebo-controlled Study of the Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)

Details for clinical trial NCT01097694